Have we been wrong about testosterone and prostate cancer all along? In this episode of BackTable Urology, Dr. Abraham Morgentaler, who pioneered the modern use of testosterone therapy, joins Dr. Amy Pearlman to discuss the evolving understanding of testosterone therapy in clinical practice and its implications on patient care.

---

SYNPOSIS

Dr. Morgentaler shares insights from his decades-long career, including his pivotal research that refuted the presumed harms of testosterone therapy and belief that it contributes to the development of prostate cancer. The conversation explores the evolution of testosterone therapy, its misunderstood role in prostate cancer, and the need for broader clinical recognition of testosterone deficiency. The discussion also explores potential future applications of testosterone therapy, including its role in perioperative optimization and the growing need for nuanced, evidence-based guidelines in men’s health care.

---

TIMESTAMPS

00:00 - Introduction
08:45 - The Evolution of Testosterone Therapy
20:10 - Challenging Conventional Wisdom on Testosterone
34:04 - Reevaluating Testosterone and Prostate Cancer
51:20 - Testosterone and Prostate Cancer Recurrence
55:44 - Managing Testosterone Therapy in Prostate Cancer Patients
01:12:45 - Final Thoughts

---

RESOURCES

The Sex Doctors:
https://www.amazon.com/The-Sex-Doctors/dp/B0DCJQ5B5Q